Ahmed, M., von Itzstein, M. S., Sheffield, T., Khan, S., Fattah, F., Park, J. Y., . . . Gerber, D. E. (2021). Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors. J Immunother Cancer.
Chicago-stil citatAhmed, Murtaza, et al. "Association between Body Mass Index, Dosing Strategy, and Efficacy of Immune Checkpoint Inhibitors." J Immunother Cancer 2021.
MLA-referensAhmed, Murtaza, et al. "Association between Body Mass Index, Dosing Strategy, and Efficacy of Immune Checkpoint Inhibitors." J Immunother Cancer 2021.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.